Thomas Charles Luke
Chief Medical Officer, SAB Biotherapeutics, Inc.
Companies
- SAB Biotherapeutics, Inc.Chief Medical Officer Oct 22, 2021 to Mar 18, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- SAB Biotherapeutics, Inc. SABS5,428 shares2$14.1K at $2.60Oct 22, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 22, 2021Granted 5,428 shares of SAB Biotherapeutics, Inc.2
- Oct 19, 2021Granted 990 shares at $10.10 of SAB Biotherapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2